Nine-valent HPV vaccine is expected to land more at the end of the year, which can prevent 90% of cervical cancer.
Beijing Youth Daily reporter learned from GlaxoSmithKline, a bivalent HPV vaccine manufacturer, that its bivalent HPV vaccine "sirrah Shi" was approved for new vaccination, and the vaccination age was extended to 9-45 years old. At present, there are two kinds of HPV vaccines that can be vaccinated in this city, bivalent HPV vaccine and tetravalent HPV vaccine, of which the tetravalent vaccination age is 20-45 years old.
At the end of the year, 9-valent HPV vaccine is expected to land more.
At present, there are three kinds of HPV vaccines listed in China: bivalent, bivalent and bivalent, and bivalent and bivalent can be vaccinated in Beijing. On April 29th, National Medical Products Administration announced that it had conditionally approved the marketing of 9-valent HPV vaccine for preventing cervical cancer. However, from the time the vaccine is approved for listing in China to the time it can be vaccinated, it must go through the links of online price limit, procurement announcement, bidding and evaluation, and then the CDC at all levels will formally place an order for procurement and sales. Many insiders predict that the 9-valent HPV vaccine is expected to land in many places in China at the end of the year.
Among them, "valence" represents the kind of virus that can be prevented by vaccine. A bivalent vaccine can prevent infection by HPV16 and HPV18 viruses. International research data show that more than 70% of cervical cancer is caused by these two viruses. The tetravalent vaccine can prevent HPV infection of types 6, 11, 16 and 18. Although HPV6 and HPV11 are not high-risk HPV viruses of cervical cancer, they can cause vulvar condyloma acuminatum. Nine-valent vaccine is aimed at nine subtypes of HPV6, 11, 16, 18, 31, 33, 45, 52 and 58. International research data show that nine-valent vaccine can prevent 90% of cervical cancer.
The 9-valent HPV vaccine has not been vaccinated in Beijing yet.
At present, the vaccination clinic of the community health service center in this city can make an appointment for HPV vaccination. Official website of Beijing Municipal Health Planning Commission and Beijing Municipal Center for Disease Control and Prevention has the address, appointment telephone number and opening hours of vaccination clinics of community health service centers.
HPV vaccine is usually administered in three injections for a total of six months to be effective. The target of bivalent HPV vaccine is the female population aged 9 -45, and the immunization program is one dose at the 0 th, 1 ST and 6 th month respectively. Four-valent vaccination targets were 20 -45 years old, and the immunization program was inoculated with one dose at the 0 th, 2 nd and 6 th months respectively. At present, the approved vaccination targets in China are women aged 16-26, and the immunization program is to vaccinate 1 dose at the 0 th, 2 nd and 6 th month.
Because it is a second-class vaccine, the vaccination of HPV vaccine is at its own expense. Among them, the price of bivalent HPV vaccine in 580 yuan is 1,740 yuan. The 4-valent HPV vaccine is 798 yuan/piece, and the price of 3 pieces in the whole process is 2394 yuan. The 9-valent HPV vaccine has not yet been vaccinated in Beijing.
Choose different valence vaccines according to their age and economic situation.
National Medical Products Administration suggested that the public can choose to vaccinate HPV vaccine with different valence types according to their age and economic situation. HPV vaccination is best before women have their first substantive sexual contact. The recommended age in the United States is 9-26. But even if you have had sex, you can still be vaccinated. It should be reminded that regular screening is still needed after vaccination regardless of bivalent vaccine, tetravalent vaccine or nine-valent vaccine. Existing vaccines, including the 9-valent vaccine, cannot prevent all high-risk HPV. Moreover, there may be a small number of high-risk HPV that have not been identified at present, and of course there is no targeted vaccine.
Text/Reporter Zhang Xiaomei Zhao Xinpei Photo courtesy/vision china
related news
The 9-valent cervical cancer vaccine will be launched soon.
The first domestic nine-valent cervical cancer (HPV) vaccine is expected to be vaccinated in Hainan today. At the end of April this year, National Medical Products Administration conditionally approved the marketing of nine-valent cervical cancer vaccine for preventing cervical cancer. The vaccine is suitable for women aged 16 to 26. The industry believes that it will take some time from the current "conditional" approval to the nationwide normal vaccination.
Hainan Boao Hejia International Medical Center recently announced that it will open a nine-valent HPV vaccine appointment for the whole country from now on, and the first shot will be vaccinated on May 30. The relevant person in charge of Hejia said, "Hejia is the only institution in Hainan that can make an appointment and vaccinate the nine-valent HPV vaccine. According to the current appointment, we have arranged 15 vaccinators to vaccinate on May 30." It is understood that the nine-valent cervical cancer vaccine immunization program is to vaccinate three needles in the 0 th, 2 nd and 6 th months.
The Hainan Provincial Health Planning Commission recently announced that the first batch of about 2,000 nine-valent HPV vaccines has arrived in Qionghai. The first batch of vaccines can be inoculated for 2000 people, with a total of 6000 vaccines. It is reported that the winning bid price of two specifications of the nine-valent HPV vaccine is 1298 yuan/piece, and the total amount of three injections is 3894 yuan. Text/reporter Zhao Xinpei
News memory
What is HPV vaccine?
HPV is the abbreviation of the English name of "human papillomavirus". There are more than 100 members in the HPV family, some of which are closely related to malignant tumors, and are called high-risk HPV.
The probability that a woman who has sex has been infected with HPV in her life is as high as 40%-80%. However, more than 80% of HPV infections will be cleared naturally within 8 months, and only a few persistent high-risk HPV infections can cause cancer for more than 2 years.
Among those who continue to be infected, only a few people will develop cervical precancerous lesions, and only a few of them will develop cancer.
Therefore, for most people, being infected with HPV virus is like "getting a cold in the cervix", so don’t be too nervous and afraid.
HPV vaccine is the first vaccine to prevent tumor in the world, and human beings try to eliminate a cancer through vaccine for the first time. This vaccine uses a special protein shell on the virus to trigger human immunity. Therefore, the vaccine itself is not a virus, but a protein, which has no virus function and will not cause virus infection. Text/reporter Zhang Xiaomei